BeyondSpring, Inc. - Ordinary Shares (BYSI): Price and Financial Metrics
BYSI Price/Volume Stats
| Current price | $2.37 | 52-week high | $4.00 |
| Prev. close | $2.37 | 52-week low | $0.65 |
| Day low | $2.25 | Volume | 18,300 |
| Day high | $2.45 | Avg. volume | 100,371 |
| 50-day MA | $2.03 | Dividend yield | N/A |
| 200-day MA | $2.04 | Market Cap | 92.50M |
BYSI Stock Price Chart Interactive Chart >
BeyondSpring, Inc. - Ordinary Shares (BYSI) Company Bio
BeyondSpring is a global clinical stage biopharmaceutical company developing innovative immuno-oncology cancer therapies. The co is advancing its lead asset, Plinabulin, into a Phase 3 clinical trial as a direct anticancer agent in non-small cell lung cancer and a Phase 2/3 clinical trial in the prevention of chemotherapy-induced Neutropenia.
BYSI Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...